COMP <GO>
SLDB vs AURA // EV/EBITDA & P/E VALUATION
Solid Biosciences Inc. (NASDAQ) VS. Aura Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: SLDB 1
— AURA 3
■ METRIC PARITY
LAST: $6.00 (-3.23%) • MKT CAP: $664.8M
valuation
—
LAST: $6.03 (-1.79%) • MKT CAP: $636.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLDB VS. AURA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SLDB | AURA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -22.98% | -13.05% | -9.93 | AURA | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | AURA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 43.5 | -0.50 | AURA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $664.8M | $636.7M | $28.0M | SLDB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SLDB REV | AURA REV | SLDB GROSS % | AURA GROSS % | SLDB FCF | AURA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.8M | $315.8M | — | — | -$157.4M | -$85.2M |
| FY 2024 | $363.2M | $269.1M | — | — | -$100.7M | -$81.1M |
| FY 2023 | — | $238.0M | — | — | — | -$63.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLDB // BETA —
AURA // BETA —